Literature DB >> 1717721

Short-term treatment with gamma interferon induces stable reversion of ras-transformed mouse fibroblasts.

B Seliger1, K Pfizenmaier, R Schäfer.   

Abstract

Persistent revertants have been generated from NIH 3T3 cells transformed by an activated human Ha-ras gene after short-term gamma interferon treatment in the presence of the cardiac aminoglycoside ouabain. Normal fibroblastlike morphology and anchorage dependence are restored in revertants. Tumorigenicity in nude mice is abolished. The revertants continue to express high steady-state levels of the ras oncogene. Partial retransformation of reverted cells is induced after 5-azacytidine treatment or after infection with retrovirus vectors carrying the v-abl, v-fes, v-myc, or v-src oncogene. The revertants resist the transforming activities of the v-Ha-ras and v-mos oncogenes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717721      PMCID: PMC250340     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.

Authors:  N Kuzumaki; Y Ogiso; A Oda; H Fujita; H Suzuki; C Sato; L Müllauer
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

2.  Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine.

Authors:  D Samid; D M Flessate; R M Friedman
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

3.  The transformation-suppressive function is lost in tumorigenic cells and is restored upon transfer of a suppressor gene.

Authors:  E Iten; A Ziemiecki; R Schäfer
Journal:  Recent Results Cancer Res       Date:  1989

4.  Murine gamma interferon inhibits v-mos-induced fibroblast transformation via down regulation of retroviral gene expression.

Authors:  B Seliger; G Kruppa; K Pfizenmaier
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

5.  The myeloproliferative sarcoma virus retains transforming functions after introduction of a dominant selectable marker gene.

Authors:  W Ostertag; B Seliger; R Kollek; C Stocking; U Bergholz; F Smadja-Joffe
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

6.  Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.

Authors:  D Sergiescu; J Gerfaux; A M Joret; C Chany
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.

Authors:  A G Geiser; C J Der; C J Marshall; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  The transformation of primary and established mouse mammary epithelial cells by p21-ras is concentration dependent.

Authors:  S M Redmond; E Reichmann; R G Müller; R R Friis; B Groner; N E Hynes
Journal:  Oncogene       Date:  1988-03       Impact factor: 9.867

9.  Partial reversion of the transformed phenotype in HRAS-transfected tumorigenic cells by transfer of a human gene.

Authors:  R Schaefer; J Iyer; E Iten; A C Nirkko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  Requirement for c-ras proteins during viral oncogene transformation.

Authors:  M R Smith; S J DeGudicibus; D W Stacey
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

View more
  3 in total

1.  Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene.

Authors:  S Contente; K Kenyon; P Sriraman; S Subramanyan; R M Friedman
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

2.  Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

3.  Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione.

Authors:  A C Miller; J Gafner; E P Clark; D Samid
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.